A preliminary study of micro-RNAs as minimally invasive biomarkers for the diagnosis of prostate cancer patients

Table 3 miRs prediction of patients with high Grade vs No-Cancer + Low Grade tumors in Validation cohort 2

	Validation cohort 2
	High Grade vs No-Cancer + Low-grade
Variables	Univariate		Multivariate
	Odds ratio (CI)	p	Odds ratio (CI)	p
AGE	1.10(1.01–1.19)	.027	1.09(0.98–1.20)	.10
PSA	1.07(0.99–1.15)	.68
miR-26b-5p	.015(.000–.60)	.25	.018(.001–.85)	.041
miR-30c	.97(.90–1.04)	.34
miR-21-5p	.99(.98–1.01)	.34
miR-98-5p	.62(0.27–1.44)	.62
miR-4732-3p	1.65(1.09–2.50)	.018	1.4(.87–2.27)	.17
Let7a-5p	.99(.97–1.01)	.40

Abbreviations: CI Confident Interval, p p value, PSA Prostate Specific Antigen. Data are presented as odds ratio (CI). Empty cells correspond to variables that were not measured. Baseline variables that achieved a level of significance of p < .05 in the univariate analysis were entered into multivariate models

ISSN: 1756-9966